Wei Xue

766 total citations
59 papers, 559 citations indexed

About

Wei Xue is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Wei Xue has authored 59 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Wei Xue's work include Menopause: Health Impacts and Treatments (10 papers), Estrogen and related hormone effects (9 papers) and Immunotherapy and Immune Responses (7 papers). Wei Xue is often cited by papers focused on Menopause: Health Impacts and Treatments (10 papers), Estrogen and related hormone effects (9 papers) and Immunotherapy and Immune Responses (7 papers). Wei Xue collaborates with scholars based in China, United Kingdom and United States. Wei Xue's co-authors include Rachael L. Metheringham, Peter Symonds, Lindy G. Durrant, Victoria A. Brentville, Yan Deng, Katherine Cook, Ian Daniels, Aijun Sun, Yanfang Wang and Barbara Gunn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Cancer Research.

In The Last Decade

Wei Xue

54 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xue China 15 207 172 169 72 65 59 559
Canan Cacına Türkiye 16 300 1.4× 182 1.1× 77 0.5× 21 0.3× 68 1.0× 39 567
Xiaoxia Fu China 11 191 0.9× 75 0.4× 157 0.9× 85 1.2× 42 0.6× 22 587
Fumitaka Morito Japan 15 168 0.8× 72 0.4× 270 1.6× 25 0.3× 53 0.8× 37 640
Michail Diakosavvas Greece 10 222 1.1× 104 0.6× 32 0.2× 82 1.1× 40 0.6× 35 549
Mohammad Arafa Egypt 14 223 1.1× 130 0.8× 82 0.5× 45 0.6× 33 0.5× 45 589
Ryoko Saito Japan 14 204 1.0× 235 1.4× 106 0.6× 19 0.3× 119 1.8× 77 685
Qun Liu China 15 234 1.1× 161 0.9× 39 0.2× 27 0.4× 67 1.0× 41 687
Xianrong Zhou China 15 340 1.6× 141 0.8× 65 0.4× 111 1.5× 40 0.6× 37 850

Countries citing papers authored by Wei Xue

Since Specialization
Citations

This map shows the geographic impact of Wei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xue more than expected).

Fields of papers citing papers by Wei Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xue. The network helps show where Wei Xue may publish in the future.

Co-authorship network of co-authors of Wei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xue. A scholar is included among the top collaborators of Wei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xue. Wei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaowen, Zhou Yu, Wei Xue, et al.. (2025). A case-control study on the link between trace element exposure in follicular fluid and premature ovarian insufficiency. Reproductive Toxicology. 135. 108947–108947.
2.
Wang, Fang, Jinghao Fan, Wenping Pan, et al.. (2025). Probiotic-inspired hybrid nanovesicles for enhancing immune checkpoint therapy efficiency via tumor immune microenvironment modulation. Bioactive Materials. 56. 197–216.
3.
Fan, Jinghao, Fang Wang, Shiyi Chen, et al.. (2025). Boosting Immune Checkpoint Therapy Efficacy of Pancreatic Cancer by Cell‐Anchoring Probiotic. Advanced Functional Materials. 35(50). 1 indexed citations
6.
Xue, Wei, et al.. (2024). Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy. Acta Biomaterialia. 189. 532–544. 4 indexed citations
7.
Liu, Ying, Wei Xue, Xin Chen, et al.. (2023). Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway. Journal of Ethnopharmacology. 305. 116133–116133. 11 indexed citations
8.
Xue, Wei, Wei Cang, Jun Zhao, et al.. (2023). Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia. International Journal of Gynecological Cancer. 33(8). 1222–1226. 1 indexed citations
9.
Xue, Wei, Jie Hao, Qiuping Zhang, et al.. (2022). Chlorogenic Acid Inhibits Epithelial-Mesenchymal Transition and Invasion of Breast Cancer by Down-Regulating LRP6. Journal of Pharmacology and Experimental Therapeutics. 384(2). 254–264. 23 indexed citations
10.
Wang, Qiang, Xuemei Zhang, Wenqi Wang, et al.. (2021). Effects of UCMSCs Delivered through Different Transplantation Approaches on Acute Radiation Enteritis in Rats. Cell Transplantation. 30. 4211083086–4211083086. 3 indexed citations
11.
Brentville, Victoria A., Rachael L. Metheringham, Barbara Gunn, et al.. (2016). Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity. Cancer Research. 76(3). 548–560. 80 indexed citations
12.
Chen, Qi, et al.. (2016). Ultra-mini percutaneous nephrolithotomy for the treatment of renal or upper ureteral stones (report of 32 cases). Zhonghua miniao waike zazhi. 37(6). 427–430. 1 indexed citations
13.
Li­, ­Jun, Hong Chen, Qiang Wang, et al.. (2016). Intraperitoneal Injection of Multiplacentas Pooled Cells Treatment on a Mouse Model with Aplastic Anemia. Stem Cells International. 2016(1). 3279793–3279793. 13 indexed citations
14.
Xue, Wei, Rachael L. Metheringham, Victoria A. Brentville, et al.. (2016). SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade. OncoImmunology. 5(6). e1169353–e1169353. 35 indexed citations
16.
Lv, Jianwei, et al.. (2015). Risk factors of long-term complications after Tension-Free Vaginal Tape(TVT) procedure in Chinese patients with stress urinary incontinence.. Biomedical Research-tokyo. 26(1). 0. 2 indexed citations
17.
Sun, Aijun, Yaping Wang, Wei Xue, et al.. (2012). How to determine the dosage of oral progesterone among patients with menstrual disorders?. PubMed. 125(11). 1970–4. 1 indexed citations
18.
Xue, Wei, et al.. (2012). Effective observation on prevention for mismatched intravenous infusion by patients' participation in double-identity confirmation. Zhonghua xiandai huli zazhi. 18(14). 1657–1659. 1 indexed citations
19.
Zhang, Zhen, et al.. (2010). Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line. SHILAP Revista de lepidopterología.
20.
Wang, Yue, Wei Xue, Vincent W.S. Liu, & Hys Ngan. (2006). Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor. Mitochondrion. 7(1-2). 171–175. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026